BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7811042)

  • 1. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.
    Betriu C; Gomez M; Sanchez A; Cruceyra A; Romero J; Picazo JJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2183-6. PubMed ID: 7811042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent infection associated with penicillin-tolerant group B streptococci: a report of two cases.
    Siegel JD; Shannon KM; DePasse BM
    J Pediatr; 1981 Dec; 99(6):920-4. PubMed ID: 7031213
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial susceptibility of GBS.
    Kim KS
    Antibiot Chemother (1971); 1985; 35():83-9. PubMed ID: 3901912
    [No Abstract]   [Full Text] [Related]  

  • 4. [Optimum choice of antibiotic treatment in neonatal infections due to group B streptococci].
    Bingen E; Lambert-Zechovsky N; Guihaire E; Mancy C; Aujard Y; Mathieu H
    Pathol Biol (Paris); 1986 May; 34(5):530-3. PubMed ID: 3534738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of bactericidal activity against group B streptococci with reduced penicillin susceptibility by uptake of gentamicin into cells resulting from combination with β-lactam antibiotics.
    Ebara Y; Morozumi M; Sato M; Moritoki N; Toyofuku M; Takata M; Murata M; Ubukata K; Iwata S
    J Infect Chemother; 2017 May; 23(5):312-318. PubMed ID: 28341517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rate of slowly-killed-by-ampicillin phenotype among group B streptococci with reduced penicillin susceptibility.
    Taniguchi R; Kimura K; Miyazaki A; Banno H; Jin W; Yamada K; Wachino JI; Arakawa Y
    J Antimicrob Chemother; 2017 Mar; 72(3):941-942. PubMed ID: 27999012
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci.
    Baker CN; Thornsberry C; Facklam RR
    Antimicrob Agents Chemother; 1981 May; 19(5):716-25. PubMed ID: 7027921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First molecular characterization of group B streptococci with reduced penicillin susceptibility.
    Kimura K; Suzuki S; Wachino J; Kurokawa H; Yamane K; Shibata N; Nagano N; Kato H; Shibayama K; Arakawa Y
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2890-7. PubMed ID: 18490507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of group B streptococci with reduced penicillin susceptibility recurrently isolated from a sacral decubitus ulcer.
    Nagano N; Kimura K; Nagano Y; Yakumaru H; Arakawa Y
    J Antimicrob Chemother; 2009 Dec; 64(6):1326-8. PubMed ID: 19837716
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibiotic-killing kinetics of group B streptococci.
    Schauf V; Deveikis A; Riff L; Serota A
    J Pediatr; 1976 Aug; 89(2):194-8. PubMed ID: 781200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility patterns of Streptococcus agalactiae in a German university hospital.
    Ruess M; Müller U; Sander A; Berner R
    Scand J Infect Dis; 2000; 32(6):623-6. PubMed ID: 11200371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive group B Streptococcus isolates showing reduced susceptibility to penicillin in Hong Kong.
    Chu YW; Tse C; Tsang GK; So DK; Fung JT; Lo JY
    J Antimicrob Chemother; 2007 Dec; 60(6):1407-9. PubMed ID: 17959733
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility of Zimbabwean Streptococcus agalactiae (group B Streptococcus; GBS) isolates to four different antibiotics.
    Moyo SR; Maeland JA; Munemo ES
    Cent Afr J Med; 2001; 47(9-10):226-9. PubMed ID: 12808772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan.
    Seki T; Kimura K; Reid ME; Miyazaki A; Banno H; Jin W; Wachino J; Yamada K; Arakawa Y
    J Antimicrob Chemother; 2015 Oct; 70(10):2725-8. PubMed ID: 26169560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillin tolerance in group B streptococci isolated from infected neonates.
    Kim KS; Anthony BF
    J Infect Dis; 1981 Nov; 144(5):411-9. PubMed ID: 7031141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance patterns of group B streptococcal clinical isolates.
    Simoes JA; Aroutcheva AA; Heimler I; Faro S
    Infect Dis Obstet Gynecol; 2004; 12(1):1-8. PubMed ID: 15460188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci.
    Swingle HM; Bucciarelli RL; Ayoub EM
    J Infect Dis; 1985 Sep; 152(3):515-20. PubMed ID: 3897398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic sensitivity of Streptococcus group B].
    Borderon JC; Borderon E; Geslin P; Sissia G; Valla M
    Pathol Biol (Paris); 1984 Jan; 32(1):35-9. PubMed ID: 6366705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of gentamycin combined with beta-lactam antibiotics against penicillin-resistant and non-resistant Streptococcus agalactiae].
    Villar H; Jugo M; Farinati A
    Enferm Infecc Microbiol Clin; 1994 Oct; 12(8):385-9. PubMed ID: 7981289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility.
    Kimura K; Nagano N; Nagano Y; Suzuki S; Wachino J; Shibayama K; Arakawa Y
    J Antimicrob Chemother; 2013 Mar; 68(3):539-42. PubMed ID: 23111853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.